首页 | 本学科首页   官方微博 | 高级检索  
     


A phase I study of volasertib combined with afatinib,in advanced solid tumors
Authors:Jean-Pascal Machiels  Marc Peeters  Catherine Herremans  Veerle Surmont  Pol Specenier  Marina De Smet  Korinna Pilz  Natalja Strelkowa  Dan Liu  Sylvie Rottey
Affiliation:1. Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Avenue Hippocrate 10, 1200, Brussels, Belgium
2. Department of Oncology, Antwerp University Hospital, Wijlrijkstraat 10, 2650, Edegem, Belgium
3. Department of Respiratory Medicine/Thoracic Oncology, Ghent Hospital University, Pintelaan 185, 9000, Ghent, Belgium
4. Clinical Operations, SCS Boehringer Ingelheim Comm.V, Avenue Ariane 16, 1200, Brussels, Belgium
5. Global Clinical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany
6. ClinDevConsult GmbH, Egginger Str. 22/1, 89155, Erbach, Germany
7. Global Biometry and Clinical Applications, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany
8. Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany
9. Department of Medical Oncology Ghent University Hospital, Heymans Institute of Pharmacology, Ghent University, Pintelaan 185, 9000, Ghent, Belgium
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号